Market Cap 1.09B
Revenue (ttm) 631.45M
Net Income (ttm) 69.19M
EPS (ttm) N/A
PE Ratio 5.90
Forward PE 5.51
Profit Margin 10.96%
Debt to Equity Ratio 2.52
Volume 228,600
Avg Vol 417,128
Day's Range N/A - N/A
Shares Out 31.50M
Stochastic %K 33%
Beta 0.65
Analysts Strong Sell
Price Target $44.60

Company Profile

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-dete...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 781 713 3699
Address:
100 Technology Center Drive, Suite 300, Stoughton, United States
jewell69
jewell69 Oct. 3 at 6:20 PM
TRYING 2 BY 90 $DKNG 35.10 now b a .21 x .22 moved from Greece $GREK to Chile $ECH TOOK 1.4% PROFIT IN $COLL B YESTERDAY, 10/2 SOLD TODAY 10/3
0 · Reply
jewell69
jewell69 Oct. 3 at 6:00 PM
$COLL B 10/2 34.30 S TODAY 10/3 34.66
0 · Reply
hawkmdend
hawkmdend Oct. 3 at 3:43 PM
$CING I have to add $COLL as a potential buyer/partner. The new Chief Legal Officer, Nilay Patel, comes from Ironshore Pharm, which Collegium acquired to expand its presence in the ADHD/CNS space. This is getting very interesting… my Money is with COLL or $SUPN. I'm done with my DD. Happy trading, nothing else to add.
1 · Reply
jewell69
jewell69 Oct. 2 at 5:10 PM
$COLL trying 2 by 200 34.30 now 1:04 pm edt b a 34.39 x .42 recent historical trades: 09/19/2025 Sell COLLEGIUM PHARMACEUTICAL 100 $35.8159 $0.02 $3,581.57 09/15/2025 Buy COLLEGIUM PHARMACEUTICAL 100 $34.92 -$3,492.00 09/11/2025 Sell COLLEGIUM PHARMACEUTICAL 100 $38.5246 $0.02 $3,852.44 09/08/2025 Buy COLLEGIUM PHARMACEUTICAL 50 $37.58 -$1,879.00 09/08/2025 Buy COLLEGIUM PHARMACEUTICAL 50 $38.09 -$1,904.50 05/23/2025 Sell COLLEGIUM PHARMACEUTICAL 22 $27.06 $595.32 05/20/2025 Buy COLL GIUM PHARMECEUTICAL 22 $30.11 -$662.42 05/20/2025 Sell
0 · Reply
TalkMarkets
TalkMarkets Sep. 27 at 3:20 AM
Don't Overlook These 2 Highly Ranked Medical Stocks: COLL, MASI $MASI $COLL Also $ALC $SONVY https://talkmarkets.com/content/stocks--equities/dont-overlook-these-2-highly-ranked-medical-stocks-coll-masi?post=525107
0 · Reply
AnneLee847
AnneLee847 Sep. 21 at 5:55 AM
$COLL Cosmetic dermatology play. Testing multi-month support. Volume decline concerning.
0 · Reply
highnihilism
highnihilism Sep. 17 at 11:55 AM
IWM: Russell 2000 → $COLL Collegium Pharmaceutical $RSVR Reservoir Media $PRA Proassurance $FENC Fennec Pharmaceuticals $CNNE Cannae Holdings
0 · Reply
jewell69
jewell69 Sep. 15 at 7:41 PM
buying both $QURE and $COLL on a mkt on close order today 9/15/25 bad luck, bought $COLL JUST LAST FRIDAY 9/12
0 · Reply
jewell69
jewell69 Sep. 8 at 7:15 PM
$COLL 2nd buy today throwing good money after bad. Buy 50 Limit $37.58 Day $37.58 $37.90 $37.91 $37.94
0 · Reply
jewell69
jewell69 Sep. 8 at 2:56 PM
$COLL got opium ? truth be told; pain medicine Settlement date: 09/09/2025 Action: Bought Quantity: 50 Symbol: COLL Unit price: $38.09 Principal amount $1,904.5*
0 · Reply
Latest News on COLL
Collegium to Participate in Upcoming Investor Conferences

Aug 28, 2025, 8:00 AM EDT - 5 weeks ago

Collegium to Participate in Upcoming Investor Conferences


Collegium Announces $150 Million Share Repurchase Program

Jul 7, 2025, 8:00 AM EDT - 3 months ago

Collegium Announces $150 Million Share Repurchase Program


Collegium Provides 2025 Financial Guidance and Business Update

Jan 8, 2025, 8:00 AM EST - 9 months ago

Collegium Provides 2025 Financial Guidance and Business Update


Collegium Reports Record Third Quarter 2024 Financial Results

Nov 7, 2024, 4:02 PM EST - 11 months ago

Collegium Reports Record Third Quarter 2024 Financial Results


Collegium Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 4:01 PM EDT - 1 year ago

Collegium Reports Second Quarter 2024 Financial Results


Collegium Reports First Quarter 2024 Financial Results

May 9, 2024, 4:02 PM EDT - 1 year ago

Collegium Reports First Quarter 2024 Financial Results


Top 10 Small-Cap Stocks (SA Quant)

Mar 12, 2024, 5:00 AM EDT - 1 year ago

Top 10 Small-Cap Stocks (SA Quant)

ANIP APOG BASE BLBD GCT PLMR RAMP


Collegium Reports Third Quarter 2023 Financial Results

Nov 7, 2023, 4:01 PM EST - 2 years ago

Collegium Reports Third Quarter 2023 Financial Results


Collegium Pharmaceutical: Delivering On Promises

Oct 24, 2023, 2:59 PM EDT - 2 years ago

Collegium Pharmaceutical: Delivering On Promises


jewell69
jewell69 Oct. 3 at 6:20 PM
TRYING 2 BY 90 $DKNG 35.10 now b a .21 x .22 moved from Greece $GREK to Chile $ECH TOOK 1.4% PROFIT IN $COLL B YESTERDAY, 10/2 SOLD TODAY 10/3
0 · Reply
jewell69
jewell69 Oct. 3 at 6:00 PM
$COLL B 10/2 34.30 S TODAY 10/3 34.66
0 · Reply
hawkmdend
hawkmdend Oct. 3 at 3:43 PM
$CING I have to add $COLL as a potential buyer/partner. The new Chief Legal Officer, Nilay Patel, comes from Ironshore Pharm, which Collegium acquired to expand its presence in the ADHD/CNS space. This is getting very interesting… my Money is with COLL or $SUPN. I'm done with my DD. Happy trading, nothing else to add.
1 · Reply
jewell69
jewell69 Oct. 2 at 5:10 PM
$COLL trying 2 by 200 34.30 now 1:04 pm edt b a 34.39 x .42 recent historical trades: 09/19/2025 Sell COLLEGIUM PHARMACEUTICAL 100 $35.8159 $0.02 $3,581.57 09/15/2025 Buy COLLEGIUM PHARMACEUTICAL 100 $34.92 -$3,492.00 09/11/2025 Sell COLLEGIUM PHARMACEUTICAL 100 $38.5246 $0.02 $3,852.44 09/08/2025 Buy COLLEGIUM PHARMACEUTICAL 50 $37.58 -$1,879.00 09/08/2025 Buy COLLEGIUM PHARMACEUTICAL 50 $38.09 -$1,904.50 05/23/2025 Sell COLLEGIUM PHARMACEUTICAL 22 $27.06 $595.32 05/20/2025 Buy COLL GIUM PHARMECEUTICAL 22 $30.11 -$662.42 05/20/2025 Sell
0 · Reply
TalkMarkets
TalkMarkets Sep. 27 at 3:20 AM
Don't Overlook These 2 Highly Ranked Medical Stocks: COLL, MASI $MASI $COLL Also $ALC $SONVY https://talkmarkets.com/content/stocks--equities/dont-overlook-these-2-highly-ranked-medical-stocks-coll-masi?post=525107
0 · Reply
AnneLee847
AnneLee847 Sep. 21 at 5:55 AM
$COLL Cosmetic dermatology play. Testing multi-month support. Volume decline concerning.
0 · Reply
highnihilism
highnihilism Sep. 17 at 11:55 AM
IWM: Russell 2000 → $COLL Collegium Pharmaceutical $RSVR Reservoir Media $PRA Proassurance $FENC Fennec Pharmaceuticals $CNNE Cannae Holdings
0 · Reply
jewell69
jewell69 Sep. 15 at 7:41 PM
buying both $QURE and $COLL on a mkt on close order today 9/15/25 bad luck, bought $COLL JUST LAST FRIDAY 9/12
0 · Reply
jewell69
jewell69 Sep. 8 at 7:15 PM
$COLL 2nd buy today throwing good money after bad. Buy 50 Limit $37.58 Day $37.58 $37.90 $37.91 $37.94
0 · Reply
jewell69
jewell69 Sep. 8 at 2:56 PM
$COLL got opium ? truth be told; pain medicine Settlement date: 09/09/2025 Action: Bought Quantity: 50 Symbol: COLL Unit price: $38.09 Principal amount $1,904.5*
0 · Reply
jewell69
jewell69 Sep. 6 at 7:39 PM
set it, and forget it ! for Monday, trying to buy 50 $COLL 38.09 rationale: -.6% lower than friday 9/5/25 close
0 · Reply
jewell69
jewell69 Sep. 6 at 7:34 PM
$COLL modest+ earnings beat 8/7/25; up about a half a ton since then, but -3.04% last 10 trading days; including -2.32% on Friday 9/5 traded out of it for smallish profits Date Jun-06-2025 Shares -500.000 Price $29.85 Amount $14,923.75 friday 9/5 close 38.32 obviously, you would be paying up since 8/7 earnings beat
0 · Reply
Doozio
Doozio Sep. 6 at 4:03 AM
$COLL it was always 🐒🍌🧠⏰♾️ wen yo wud get tight with the da huckleberries below da $$$$$. Whuts that 🐑 short interest????
0 · Reply
Estimize
Estimize Aug. 25 at 1:03 PM
Wall St is expecting 1.88 EPS for $COLL Q3 [Reporting 11/06 BMO] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co
0 · Reply
MergeMarkets
MergeMarkets Aug. 23 at 10:01 AM
$COLL Collegium Pharmaceutical Inc is facing opioid litigation concerns and generic competition risks
0 · Reply
stockpicker63
stockpicker63 Aug. 15 at 6:04 PM
Nice profits on the free tips van Swingstocktraders. $AUPH now +34%, $PLUG now +16%, $ELAN +5%, $COLL +5.5%, $KOD +18%.
1 · Reply
net0trader
net0trader Aug. 13 at 6:56 PM
$ANIP $CELC $COLL I am out of all 3 names ..
0 · Reply
net0trader
net0trader Aug. 13 at 1:56 AM
$ANIP $CELC $COLL these really exceeded my expectations... Quite some momentum
0 · Reply
stockpicker63
stockpicker63 Aug. 11 at 1:57 PM
Stocks to watch now! $COLL and $ELAN
0 · Reply
JarvisFlow
JarvisFlow Aug. 11 at 11:00 AM
HC Wainwright & Co. updates rating for Collegium Pharmaceutical ( $COLL ) to Buy, target set at 44.
0 · Reply
net0trader
net0trader Aug. 10 at 8:38 PM
Some of the XBI names I am watching this week $ANIP $CELC $COLL . Cc @RonIsWrong
1 · Reply
d_risk
d_risk Aug. 7 at 2:28 PM
$COLL - Collegium Pharmaceutical Inc. Common Stock - 10Q - Updated Risk Factors COLL’s 10-Q Risk Factors section returns with expanded, detailed disclosures covering business, financial, commercialization, IP, third-party, legal, regulatory, market, and stock risks, adding a comprehensive risk summary without removing prior content. #Pharmaceuticals #MarketVolatility #IntellectualProperty #RegulatoryCompliance #RiskManagement 🟢 Added 🟠 Removed https://d-risk.ai/COLL/10-Q/2025-08-07
0 · Reply